GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Themis Medicare Ltd (NSE:THEMISMED) » Definitions » Debt-to-Equity

Themis Medicare (NSE:THEMISMED) Debt-to-Equity : 0.20 (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Themis Medicare Debt-to-Equity?

Themis Medicare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹576 Mil. Themis Medicare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹239 Mil. Themis Medicare's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₹4,120 Mil. Themis Medicare's debt to equity for the quarter that ended in Sep. 2024 was 0.20.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Themis Medicare's Debt-to-Equity or its related term are showing as below:

NSE:THEMISMED' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.2   Med: 0.47   Max: 2.17
Current: 0.2

During the past 13 years, the highest Debt-to-Equity Ratio of Themis Medicare was 2.17. The lowest was 0.20. And the median was 0.47.

NSE:THEMISMED's Debt-to-Equity is ranked better than
57.63% of 826 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs NSE:THEMISMED: 0.20

Themis Medicare Debt-to-Equity Historical Data

The historical data trend for Themis Medicare's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Themis Medicare Debt-to-Equity Chart

Themis Medicare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.40 0.28 0.27 0.25

Themis Medicare Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 N/A 0.25 N/A 0.20

Competitive Comparison of Themis Medicare's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Themis Medicare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Themis Medicare's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Themis Medicare's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Themis Medicare's Debt-to-Equity falls into.



Themis Medicare Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Themis Medicare's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Themis Medicare's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Themis Medicare  (NSE:THEMISMED) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Themis Medicare Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Themis Medicare's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Themis Medicare Business Description

Traded in Other Exchanges
Address
Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.

Themis Medicare Headlines

No Headlines